Why is lipitor pricier than pravastatin?

Why does Lipitor cost more than pravastatin?

Lipitor is a brand-name drug with active ingredient atorvastatin, while pravastatin is available as a generic. Brand-name drugs keep higher prices because companies recover research, development, and marketing costs incurred before launch. Generic manufacturers skip these expenses and compete mainly on price, pulling average prices down 80-85% once multiple suppliers enter the market.

Lipitor patent and exclusivity timeline

Lipitor lost U.S. patent protection in November 2011. Atorvastatin generics entered the market almost immediately. By 2013, generic versions of atorvastatin had already lowered overall statin prices sharply. Pravastatin generics arrived earlier, around 2006, so its price has remained stable since then.

How long will Lipitor remain brand-name priced?

No brand-name Lipitor remains available in the U.S. Lipitor is now supplied only as generic atorvastatin. The difference users still perceive is between early-entry generic atorvastatin and fully commoditized pravastatin. Atorvastatin generics cost more than pravastatin because fewer manufacturers compete for that molecule than for pravastatin.

What factors keep atorvastatin prices above pravastatin?

Atorvastatin requires more complex synthesis steps than pravastatin. More stringent purity requirements and fewer active suppliers limit supply and keep price margins wider. Supply disruptions or raw-material shortages can also raise prices for atorvastatin but not pravastatin.

Can patients still access brand-name versions?

No brand-name versions of Lipitor remain under any exclusivity period. The U.S. FDA has approved 70-plus manufacturers of generic atorvastatin. The U.S. FDA has approved even more for pravastatin. More suppliers normally drive prices lower.

What insurance coverage patterns emerge for these statins?

Many insurance plans cover atorvastatin as tier 1 or tier 2 under generic tiers. Insurance tiers for pravastatin also fall under generic tiers, but pricing differences persist between the molecules themselves. Patients sometimes see Lipitor listed as a brand tier if they specifically request the original Pfizer formulation.

Who manufactures these generics?

Teva, Mylan, and Aurobindo supply major volumes of atorvastatin. Dr. Reddy's, Sun Pharma, and Dr. Reddy's supply pravastatin. Supply stability from these companies can temporarily affect local pricing.

When does any remaining exclusivity expire?

No further exclusivity remains on either molecule. Both drugs are fully genericized.